Clinical impact of the accelerate PhenoTest® BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after implementation study

BACKGROUND: The Accelerate PhenoTest® BC system (AXDX) is a novel assay for rapid bacterial identification and antimicrobial susceptibility (AST). We report an evaluation of its impact on treatment of patients with Gram-negative bacteremia (GNB) with a high risk of antimicrobial resistance (AMR). ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Brosh-Nissimov, Tal, Tzur, Anka, Grupel, Daniel, Cahan, Amos, Ma’aravi, Nir, Heled-Akiva, Maya, Jawamis, Hasan, Leskes, Hanna, Barenboim, Erez, Sorek, Nadav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387206/
https://www.ncbi.nlm.nih.gov/pubmed/37516885
http://dx.doi.org/10.1186/s12941-023-00619-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387206/
https://www.ncbi.nlm.nih.gov/pubmed/37516885
http://dx.doi.org/10.1186/s12941-023-00619-6

Ejemplares similares